1. Home
  2. AIV vs VTYX Comparison

AIV vs VTYX Comparison

Compare AIV & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apartment Investment and Management Company

AIV

Apartment Investment and Management Company

HOLD

Current Price

$5.91

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Logo Ventyx Biosciences Inc.

VTYX

Ventyx Biosciences Inc.

HOLD

Current Price

$14.04

Market Cap

990.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIV
VTYX
Founded
1975
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
990.9M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
AIV
VTYX
Price
$5.91
$14.04
Analyst Decision
Buy
Hold
Analyst Count
1
7
Target Price
$10.00
$13.50
AVG Volume (30 Days)
1.9M
5.9M
Earning Date
02-23-2026
02-26-2026
Dividend Yield
37.86%
N/A
EPS Growth
N/A
N/A
EPS
1.72
N/A
Revenue
$210,889,000.00
N/A
Revenue This Year
$6.96
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.78
N/A
Revenue Growth
39.67
N/A
52 Week Low
$5.24
$0.78
52 Week High
$9.29
$25.00

Technical Indicators

Market Signals
Indicator
AIV
VTYX
Relative Strength Index (RSI) 52.74 76.51
Support Level $5.86 $7.08
Resistance Level $5.96 $13.90
Average True Range (ATR) 0.07 0.32
MACD -0.01 0.12
Stochastic Oscillator 53.33 84.02

Price Performance

Historical Comparison
AIV
VTYX

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Share on Social Networks: